Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Bergman

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2018
Involvement of Nicotinic Receptor Subtypes in the Behavioral Effects of Nicotinic Drugs in Squirrel MonkeysSarah L Withey, Michelle R Doyle, Jack Bergman, et al.
Behavioural Pharmacology|November 9, 2007
Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in ratsRajeev I Desai, John L Neumeyer, Jack Bergman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2012
Effects of chronic buspirone treatment on cocaine self-administrationNancy K Mello, Peter A Fivel, Stephen J Kohut, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2019
Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine TreatmentSarah L Withey, Roger D Spealman, Jack Bergman, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 2, 2010
Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine effluxRajeev I Desai, Carol A Paronis, Jared Martin, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 9, 2004
Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitorsPaul W Czoty, Chinnasamy R Ramanathan, Nicole H Mutschler, et al.
European Journal of Pharmacology|January 9, 2007
Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeysRajeev I Desai, John L Neumeyer, Carol A Paronis, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Δ <sup>9</sup> -Tetrahydrocannabinol-induced enhancement of reward responsivity via mesocorticolimbic modulation in squirrel monkeysKwang-Hyun Hur, Lisa D Nickerson, Jack Bergman, et al.
Biomedicines|February 25, 2022
Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System DisordersChad R Johnson, Brian D Kangas, Emily M Jutkiewicz, et al.
Psychopharmacology|August 9, 2024
Effects of chronic naltrexone treatment on relapse-related behavior and neural responses to fentanyl in awake nonhuman primatesSarah L Withey, Harshawardhan U Deshpande, Lei Cao, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2018
Involvement of Nicotinic Receptor Subtypes in the Behavioral Effects of Nicotinic Drugs in Squirrel MonkeysSarah L Withey, Michelle R Doyle, Jack Bergman, et al.
Behavioural Pharmacology|November 9, 2007
Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in ratsRajeev I Desai, John L Neumeyer, Jack Bergman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2012
Effects of chronic buspirone treatment on cocaine self-administrationNancy K Mello, Peter A Fivel, Stephen J Kohut, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2019
Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine TreatmentSarah L Withey, Roger D Spealman, Jack Bergman, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 2, 2010
Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine effluxRajeev I Desai, Carol A Paronis, Jared Martin, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 9, 2004
Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitorsPaul W Czoty, Chinnasamy R Ramanathan, Nicole H Mutschler, et al.
European Journal of Pharmacology|January 9, 2007
Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeysRajeev I Desai, John L Neumeyer, Carol A Paronis, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Δ <sup>9</sup> -Tetrahydrocannabinol-induced enhancement of reward responsivity via mesocorticolimbic modulation in squirrel monkeysKwang-Hyun Hur, Lisa D Nickerson, Jack Bergman, et al.
Biomedicines|February 25, 2022
Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System DisordersChad R Johnson, Brian D Kangas, Emily M Jutkiewicz, et al.
Psychopharmacology|August 9, 2024
Effects of chronic naltrexone treatment on relapse-related behavior and neural responses to fentanyl in awake nonhuman primatesSarah L Withey, Harshawardhan U Deshpande, Lei Cao, et al.
Pageof 13